OncoZenge AB (8LY)
Market Open
12 Aug, 06:08
XFRA XFRA Primary €
0. 55
+0.04
+7.8586%
€
6.67M Market Cap
- P/E Ratio
- Div Yield
2,045 Volume
-1.2 Eps
€ 0.51
Previous Close Want to track 8LY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
OncoZenge AB (8LY) Statistics
Valuation metrics
Market Cap 6.67M
Enterprise value -
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2.5
Price/Book (mrq) 0.72
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 12.65M
Float 4.43M
Shares short -
% Held by insiders 0.5%
% Held by institutions 0.12%
Average volume (10 days) 409
Average volume (90 days) 409
Price summary
52-Week low 0.45
52-Week high 0.75
Beta 1.34
50-Day moving average 0.52
200-Day moving average 0.54
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -5.92%
Operational effectiveness
Return on assets -0.55%
Return on equity -1.73%
Income Statement
Revenue (ttm) 2.66M
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -15.94M
Diluted EPS (ttm) -0.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) 88.47
Current ratio (mrq) 1.01%
Book value per share (mrq) 0.74
Cash Flow
Cash flow statement -13.06M
Levered free cash flow (LFCF) -656.91K
